1. Home
  2. CUE vs ACCL Comparison

CUE vs ACCL Comparison

Compare CUE & ACCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cue Biopharma Inc.

CUE

Cue Biopharma Inc.

HOLD

Current Price

$30.39

Market Cap

17.6M

Sector

Health Care

ML Signal

HOLD

ACCL

Acco Group Holdings Limited Ordinary Shares

N/A

Current Price

$1.47

Market Cap

20.2M

ML Signal

N/A

Company Overview

Basic Information
Metric
CUE
ACCL
Founded
2014
2009
Country
United States
Hong Kong
Employees
N/A
22
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
17.6M
20.2M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
CUE
ACCL
Price
$30.39
$1.47
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$120.00
N/A
AVG Volume (30 Days)
21.7M
17.4K
Earning Date
05-13-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
61.11
N/A
EPS
N/A
N/A
Revenue
$27,466,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$17.13
Revenue Growth
195.75
N/A
52 Week Low
$0.17
$1.23
52 Week High
$30.97
$5.00

Technical Indicators

Market Signals
Indicator
CUE
ACCL
Relative Strength Index (RSI) 86.91 56.29
Support Level $0.40 $1.30
Resistance Level N/A $1.65
Average True Range (ATR) 3.25 0.09
MACD 2.47 0.01
Stochastic Oscillator 81.63 66.67

Price Performance

Historical Comparison
CUE
ACCL

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

About ACCL Acco Group Holdings Limited Ordinary Shares

Acco Group Holdings Ltd is a holding company. Through its Operating Subsidiaries, it is a multi-disciplinary, IT-driven corporate service provider with a presence in Hong Kong and Singapore. Under the Accolade brand, it specializes in offering corporate secretarial services and accounting services in Hong Kong, as well as intellectual properties (IP) registration services in Singapore. Leveraging developed IT solutions, It provides comprehensive, reliable and professional support to its clients, enabling them to focus on their core business activities while it manages and handles their corporate compliance needs. Its clientele ranges from individual clients, small and medium-sized enterprises to multinational corporations, reflecting its ability to cater to diverse business needs.

Share on Social Networks: